Francis A, Trnka P, McTaggart SJ. Long-Term Outcome of Kidney Transplantation in Recipients with Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol 2016; 11:2041. Carraro M, Caridi G, Bruschi M, et al. Serum glomerular permeability activity in patients with podocin mutations (NPHS2) an...
关键词 利妥昔单抗 局灶节段性肾小球硬化 B 细胞 足细胞 酸性鞘磷脂酶样磷酸二酯酶 3b Mechanism and efficacy of rituximab in idiopathic focal segmental glomerulosclerosis MIN Min,ZHANG Jiong,WANG Jinquan National Clinical Research Center of Kidney Disease,Jinling Hospital,Nanjing Medical University, ...
此型肾小球损伤为弥漫性,仔细的光学显微镜检查更适用于这种情况[参考文献14、Remuzzi A, Mazerska M, Gephardt GN, et al. Three-dimensional analysis of glomerular morphology in patients with subtotal nephrectomy. Kidney Int 1995; 48:155.]。一项研究显示,非连续单...
参考文献 Wheeler et al. Safety and efficacy of dapagliflozin in patients with focal segmental glomerulosclerosis: a prespecified analysis of the dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial.Nephrol Dial Transplant ...
2. Gbadegesin RA, Lavin PJ, Hall G, et al. Inverted formin 2 mutations with variable expression in patients with sporadic and hereditary focal and segmental glomerulosclerosis. Kidney Int 2012; 81:94. 3. Hinkes BG, Mucha B, Vlangos CN, et al. Nephrotic syndrome in the first year of ...
沙罗格列扎和肉豆蔻酸用于治疗局灶性节段性肾小球硬化(FSGS).pdf,本发明涉及一种包含沙罗格列扎和肉豆蔻酸或其盐或溶剂化物的药物制剂,其用于治疗局灶性节段性肾小球硬化(FSGS)。(19)国家知识产权局 (12)发明专利申请 (10)申请公布号 CN 116600802 A (43)申请公布日 2023.0
Kudose, S., et al. 'Kidney Biopsy Findings in Patients With COVID-19.'Journal of the American Society of Nephrology, 2020. 原发性FSGS的病人肾移植前需不需要预防性治疗? 原发性FSGS肾移植前的预防性治疗:最新研究和观点 现有研究和观点
Focal segmental glomerulosclerosis (FSGS) is the primary renal disease in approximately one-tenth of pediatric patients receiving a renal allograft. Recurr... S Weber,B T??Nshoff - 《Transplantation》 被引量: 100发表: 2005年 Treatment and outcome of adult patients with primary focal segmental glo...
Focal Segmental Glomerulosclerosis (FSGS)--Kidney disease in which scarring occurs in each glomerulus leading to the inability to properly filter blood. Cases in Clinical Microbiology Most steroid-resistant NS (SRNS) patients have a histological presentation of focal segmental glomerulosclerosis (FSGS).[...
Focal segmental glomerulosclerosis (FSGS) is a rare but important cause of end-stage kidney disease in children and adults. Current therapy, consisting of corticosteroids and calcineurin inhibitors, fails to achieve a sustained remission in most patients. Therefore, there is a pressing need to ...